PER 3.57% 8.7¢ percheron therapeutics limited

Sarepta gene therapy study missed key target in Duchennes, page-25

  1. 3,783 Posts.
    lightbulb Created with Sketch. 33
    https://hotcopper.com.au/data/attachments/2790/2790974-3d73e35b25dfa565a77911841ae3e7b2.jpg
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.